Cerity Partners’s AdvisorShares Pure US Cannabis ETF MSOS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$85.8K Sell
16,994
-21
-0.1% -$98 ﹤0.01% 3234
2026
Q1
$60.9K Buy
17,015
+6,561
+63% +$26.9K ﹤0.01% 3087
2025
Q4
$49.3K Hold
10,454
﹤0.01% 2805
2025
Q3
$50.1K Hold
10,454
﹤0.01% 2695
2025
Q2
$25.2K Hold
10,454
﹤0.01% 2601
2025
Q1
$27.3K Hold
10,454
﹤0.01% 2433
2024
Q4
$39.8K Buy
+10,454
New +$56.4K ﹤0.01% 2386

Other funds holding MSOS

Cerity Partners's MSOS Position: Q2 2026 in Review

Cerity Partners reduced its AdvisorShares Pure US Cannabis ETF (MSOS) stake by 0.12% in Q2 2026, selling an estimated $98 and leaving 16,994 shares worth $85.8K. The position accounts for ﹤0.01% of the portfolio, ranked #3234.

Cerity Partners first reported a position in MSOS in Q4 2024 and has held it in 7 quarters since. 156 funds tracked by Wall St. Rank hold MSOS as of Q2 2026.

  • Cerity Partners held 16,994 shares of AdvisorShares Pure US Cannabis ETF worth $85.8K as of Q2 2026.
  • Cerity Partners sold 21 AdvisorShares Pure US Cannabis ETF shares in Q2 2026, an estimated $98.
  • AdvisorShares Pure US Cannabis ETF made up ﹤0.01% of Cerity Partners's portfolio in Q2 2026, its #3234 holding.
  • Cerity Partners first reported a position in AdvisorShares Pure US Cannabis ETF in Q4 2024 and has held it in 7 quarters since.
  • 156 funds tracked by Wall St. Rank held AdvisorShares Pure US Cannabis ETF as of Q2 2026.

Based on Cerity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.